CD34 and neoplasm: Along with CD34 and CD133, tumor-associated ECs exhibit other stem cell markers including CD90, Sca-1, MDR1 ALP, and Oct-4, and form stem cell-like clusters with increased proliferative and invasive capacity and aldehyde dehydrogenase (ALDH) activity involved in resistance to therapy (26, 27, 44, 45).